HUE051024T2 - (1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol alkalmazása gyulladásos fájdalom kezelésére - Google Patents

(1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol alkalmazása gyulladásos fájdalom kezelésére

Info

Publication number
HUE051024T2
HUE051024T2 HUE17020237A HUE17020237A HUE051024T2 HU E051024 T2 HUE051024 T2 HU E051024T2 HU E17020237 A HUE17020237 A HU E17020237A HU E17020237 A HUE17020237 A HU E17020237A HU E051024 T2 HUE051024 T2 HU E051024T2
Authority
HU
Hungary
Prior art keywords
alkyl
hydrogen
optionally substituted
och
hydroxy
Prior art date
Application number
HUE17020237A
Other languages
English (en)
Inventor
Klaus Schiene
Guenter Haase
Babette-Yvonne Koegel
Elmar Friderichs
Ulrich Jahnel
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32395002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE051024(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10254785A external-priority patent/DE10254785A1/de
Priority claimed from DE2003126103 external-priority patent/DE10326103A1/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HUE051024T2 publication Critical patent/HUE051024T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
HUE17020237A 2002-11-22 2003-11-18 (1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol alkalmazása gyulladásos fájdalom kezelésére HUE051024T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10254785A DE10254785A1 (de) 2002-11-22 2002-11-22 Kombination ausgewählter Analgetika mit COX II-Inhibitoren
DE2003126103 DE10326103A1 (de) 2003-06-06 2003-06-06 Kombination ausgewählter Analgetika mit COX II-Inhibitoren

Publications (1)

Publication Number Publication Date
HUE051024T2 true HUE051024T2 (hu) 2021-03-01

Family

ID=32395002

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE17020237A HUE051024T2 (hu) 2002-11-22 2003-11-18 (1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol alkalmazása gyulladásos fájdalom kezelésére
HUE03775368A HUE033042T2 (hu) 2002-11-22 2003-11-18 Kiválasztott analgetikum kombinációja COX II-inhibitorokkal

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE03775368A HUE033042T2 (hu) 2002-11-22 2003-11-18 Kiválasztott analgetikum kombinációja COX II-inhibitorokkal

Country Status (13)

Country Link
US (7) US7786160B2 (hu)
EP (6) EP1562567B1 (hu)
AT (2) ATE465726T1 (hu)
AU (1) AU2003283410A1 (hu)
CY (4) CY1108141T1 (hu)
DE (2) DE50312678D1 (hu)
DK (4) DK1839654T3 (hu)
ES (4) ES2819854T3 (hu)
HU (2) HUE051024T2 (hu)
LT (1) LT1562567T (hu)
PT (4) PT3241550T (hu)
SI (4) SI1839654T1 (hu)
WO (1) WO2004047823A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT1562567T (lt) * 2002-11-22 2017-08-25 Grünenthal GmbH Pasirinktų analgetikų ir cox-ii slopiklių derinys
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
PL2012764T3 (pl) * 2006-04-28 2011-04-29 Gruenenthal Gmbh Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylopropylo)fenol i Paracetamol
US20070254960A1 (en) * 2006-04-28 2007-11-01 Gruenenthal Gmbh Pharmaceutical combination
AU2007247480B8 (en) * 2006-04-28 2013-04-11 Grunenthal Gmbh Pharmaceutical combination comprising 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and an NSAID
DE102007012165A1 (de) * 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
DE102007022790A1 (de) * 2007-05-11 2008-11-20 Grünenthal GmbH Axomadol zur Schmerzbehandlung bei Arthrose
KR101972299B1 (ko) * 2007-11-23 2019-08-16 그뤼넨탈 게엠베하 타펜타돌 조성물
EP2085081A1 (de) 2008-02-04 2009-08-05 Grünenthal GmbH 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz
US20100063009A1 (en) * 2008-09-05 2010-03-11 Gruenenthal Gmbh Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
CN102202660A (zh) * 2008-09-05 2011-09-28 格吕伦塔尔有限公司 包含6-二甲氨基甲基-1-(3-甲氧基-苯基)-环己烷-1，3-二醇和扑热息痛的药物组合
BRPI0921725A2 (pt) * 2008-10-30 2016-01-05 Grüenthal GmbH formas de dosagem potentes do tapentadol
SI2424514T1 (sl) * 2009-04-30 2017-05-31 Gruenenthal Gmbh Tapentadol za zdravljenje revmatoidne artritične bolečine
WO2011023392A1 (en) * 2009-08-28 2011-03-03 Grünenthal GmbH Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an antiepileptic
CN104276960B (zh) * 2014-09-26 2016-09-28 安徽省逸欣铭医药科技有限公司 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5472711A (en) 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US5330761A (en) 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5455046A (en) 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399362A (en) 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
DE4425459C2 (de) 1994-07-19 1997-11-27 Meinecke Ag H Woltmannzähler
IT1276322B1 (it) 1994-07-21 1997-10-28 Vbc Srl Procedimento per la purificazione dell'idrossido di magnesio
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
CN1349423A (zh) * 1999-03-01 2002-05-15 奥索-麦克尼尔药品公司 包含曲马多物质和选择性cox－2抑制剂药物的组合物
KR100645866B1 (ko) 1999-12-08 2006-11-15 파마시아 코포레이션 발데콕시브 조성물
DE10000312A1 (de) 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
MY120279A (en) 2000-05-26 2005-09-30 Pharmacia Corp Use of a celecoxib composition for fast pain relief
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10059411A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
UA78529C2 (en) * 2001-10-10 2007-04-10 Wyeth Corp Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
DE10225315A1 (de) * 2002-06-06 2003-12-24 Gruenenthal Gmbh Wirkstoffsalze und Ester von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol und 3-(3-Dimethylamino-1-ethyl-1-hydroxy-2-methyl- propyl)-phenol
DE10250083A1 (de) * 2002-06-17 2003-12-24 Gruenenthal Gmbh Gegen Missbrauch gesicherte Darreichungsform
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
LT1562567T (lt) 2002-11-22 2017-08-25 Grünenthal GmbH Pasirinktų analgetikų ir cox-ii slopiklių derinys

Also Published As

Publication number Publication date
DE50312678D1 (de) 2010-06-10
EP3662904A1 (de) 2020-06-10
PT1685829E (pt) 2008-05-15
AU2003283410A1 (en) 2004-06-18
EP1839654A2 (de) 2007-10-03
US20070249724A1 (en) 2007-10-25
CY1110246T1 (el) 2015-01-14
ATE391498T1 (de) 2008-04-15
EP1562567A1 (de) 2005-08-17
EP3241550A1 (de) 2017-11-08
SI1685829T1 (sl) 2008-08-31
ATE465726T1 (de) 2010-05-15
US20100280129A1 (en) 2010-11-04
CY1119082T1 (el) 2018-01-10
LT1562567T (lt) 2017-08-25
US8003701B2 (en) 2011-08-23
US8420691B2 (en) 2013-04-16
US20100280017A1 (en) 2010-11-04
US8618177B2 (en) 2013-12-31
EP1685829A1 (de) 2006-08-02
DE50309605D1 (de) 2008-05-21
ES2304659T3 (es) 2008-10-16
EP1839654A3 (de) 2007-11-07
PT1562567T (pt) 2017-08-24
PT3241550T (pt) 2020-08-11
EP1839654B1 (de) 2010-04-28
DK1839654T3 (da) 2010-08-16
ES2345062T3 (es) 2010-09-14
US7786160B2 (en) 2010-08-31
US10471079B2 (en) 2019-11-12
US20050277687A1 (en) 2005-12-15
ES2819854T3 (es) 2021-04-19
DK1562567T3 (en) 2017-07-17
EP1562567B1 (de) 2017-06-14
SI1839654T1 (sl) 2010-08-31
US20130109733A1 (en) 2013-05-02
ES2640404T3 (es) 2017-11-02
PT1839654E (pt) 2010-07-06
US8404749B2 (en) 2013-03-26
HUE033042T2 (hu) 2017-11-28
CY1108141T1 (el) 2014-04-09
DK3241550T3 (da) 2020-08-24
EP1839654B9 (de) 2012-01-11
CY1123286T1 (el) 2021-12-31
EP1685829B1 (de) 2008-04-09
EP3241550B1 (de) 2020-07-22
US20160279150A1 (en) 2016-09-29
SI1562567T1 (sl) 2017-09-29
EP1908460A1 (de) 2008-04-09
SI3241550T1 (sl) 2020-11-30
WO2004047823A1 (de) 2004-06-10
DK1685829T3 (da) 2008-07-21
US20100280126A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
CY1123286T1 (el) Χρηση (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης για την αγωγη του φλεγμονωδους πονου
HRP20110078T1 (hr) Postupak reduciranja alfa, beta nezasićenih ketona u opioidnim sastavima
EP1022026A3 (en) Pharmaceutical compositions for treating nitrate-induced tolerance
MXPA02005604A (es) Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa.
RS20060437A (en) Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof
RU2006102355A (ru) Средство, снижающее содержание холестерина в сыворотке крови, или средство для предотвращения или терапии атеросклероза
PT1683522E (pt) Benzoxazinas para a prevenção ou o tratamento da hiperalgesia induzida pelos compostos morfínicos
AR009484A1 (es) Un compuesto de acido n-sustituido-2-amino-4-fenil-4-oxo-butanoico, su utilizacion como inhibidor de la quinurenina-3-hidroxilasa y una composicionfarmaceutica que lo comprende.
ES2160560T1 (es) Colorantes o,o'-dihidroxi-azoicos como constituyentes de medicamentos para el tratamiento de trombopenias.
WO2000051589A3 (en) VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
DE60141641D1 (de) Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen
ES2119816T3 (es) Utilizacion de una composicion de aditivo para mejorar la filtrabilidad de composiciones lubricantes en presencia de agua.
Korolkiewicz et al. The role and interactions of nitric oxide (NO), carbon monoxide (CO), and prostanoids in the pathogenesis of postoperative ileus in rats
ATE500833T1 (de) Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen
GB0412865D0 (en) Chemical compounds
ATE341609T1 (de) Zusammensetzung enthaltend eine mischung aus mono-und polylactylalkyllactaten
AR019664A1 (es) Composicion para el tratamiento de enfermedades del cartilago
Maeda et al. Neuronal mechanism of the inhibitory effect of calcitonin on N-methyl-D-aspartate-induced aversive behavior
WO2023108291A8 (en) Apelinergic macrocycles and uses thereof
TW351667B (en) Antibacterial-antifungal composition
DE69923698D1 (de) Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung
RU99100316A (ru) Новые производные аминокислот и их применение в качестве ингибиторов тромбина
UY25608A1 (es) Procedimiento e intermedios para preparar naftiridonas
AR010986A1 (es) Compuestos inhibidores de naaladasa, composicion farmaceutica que los comprende y uso de los compuestos
CO4770954A1 (es) Procedimiento mejorado para preparar derivados de ciclopentano aromaticos fusionados en el anillo